YDL223C (HBT1) umenzi we-powder CAS No.: 489408-02-8 99% ubumsulwa min. okwengeza izithako
Ividiyo Yomkhiqizo
Amapharamitha womkhiqizo
Igama lomkhiqizo | I-HBT1 |
Elinye igama | YDL223C |
Inombolo ye-CAS. | 489408-02-8 |
Ifomula yamangqamuzana | I-C16H17F3N4O2S |
Isisindo samangqamuzana | 386.40 |
Ubumsulwa | 99.0% |
Ukubukeka | Okuqinile okuphuzi okukhanyayo |
Ukupakisha | 1kg isikhwama ngasinye 25kg isigubhu ngasinye |
Isicelo | izidakamizwa ze-nootropic |
Isingeniso somkhiqizo
I-HBT1 ibophezela kusizinda esibopha i-ligand se-α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPA-R) ngendlela encike ku-glutamate. Lokhu kusho ukuthi i-HBT1 i-molecule engabophezela kuphela endaweni ethile kuphrotheni ye-AMPA-R uma kukhona i-glutamate, futhi lokhu kubophezela kusiza ukulawula umsebenzi wephrotheni. Ama-receptors e-AMPA avezwa kulo lonke uhlelo lwezinzwa olumaphakathi futhi adlala indima ebalulekile ekuxhumaneni kwe-neuronal, ukucubungula izinzwa, ukufunda, inkumbulo, kanye ne-synaptic plasticity. Ama-receptors e-AMPA angabavikeli abakhulu ekudluliselweni kwemithambo-luvo okujabulisayo, alamula ngokushesha, ngokushesha aqede ukungezwani komzimba kuma-synapses amaningi, futhi abandakanyeka ekuphenduleni kwangaphambi kwesikhathi kwe-glutamate ezifundeni ze-synaptic. Ama-receptors e-AMPA avame ukuvezwa ngokubambisana nama-NMDA receptors kuma-synapses, futhi ndawonye akhuthaza izinqubo ze-synaptic plasticity ezibandakanyeka ekufundeni, inkumbulo, i-excitotoxicity, kanye ne-neuroprotection. I-brain-derived neurotrophic factor (BDNF) iyisici se-neurotrophic esidlala indima ebalulekile ekugcinweni nasekukhuliseni ama-neurons futhi sinemiphumela enamandla futhi eminingi ekwandeni, ukuhlukaniswa, ukusinda nokufa kwamaseli e-neuronal kanye ne-non-neuronal. , i-modulator ye-neurotransmitter efaka isandla ku-neuronal plasticity ekufundeni nasenkumbulo. Ngakho-ke, kubalulekile empilweni nasenhlalakahleni yesimiso sezinzwa.
Isici
(1) Ukuhlanzeka okuphezulu: I-HBT1 ingathola imikhiqizo ehlanzekile ngezinqubo zokukhiqiza zokucwenga. Ukuhlanzeka okuphezulu kusho i-bioavailability engcono kanye nokusabela okungekuhle okumbalwa.
(2) Ukuphepha: I-HBT1 ifakazelwe ukuthi iphephile emzimbeni womuntu.
(3) Ukuzinza: I-HBT1 inokuzinza okuhle futhi ingagcina umsebenzi wayo nomthelela ngaphansi kwezimo ezihlukene nezimo zokulondoloza.
Izinhlelo zokusebenza
I-HBT1 iyinoveli yesithuthukisi se-AMPA ene-agonism ephansi, eyenga ukukhiqizwa kwe-brain-derived neurotrophic factor (BDNF) futhi inemiphumela emincane ye-agonistic kuma-neuron ayinhloko. I-HBT1 ibophezela kusizinda esibopha i-ligand se-AMPA-R ngendlela encike ku-glutamate. Ngokubambisana, bakhuthaza izinqubo ze-synaptic plasticity ezibandakanyeka ekufundeni, inkumbulo, ukujabula, kanye ne-neuroprotection. Ingathuthukisa ikhono lobuchopho nenkumbulo, futhi ithuthukise ikhono lokufunda labantu. Ngokuvamile yengezwa ekudleni kwansuku zonke ngendlela yezithako zokudla.